Sorrento Therapeutics (OTC: SRNE.Q)
Sorrento Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Sorrento Therapeutics Company Info
Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company’s non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.
News & Analysis
Why Sorrento Therapeutics Stock Crashed Today
Any euphoria after the biotech stock's big jump yesterday didn't last long.
Why Shares of Sorrento Therapeutics Are Up Today
The company is walling off subsidiary Scilex from its bankruptcy proceedings.
Why Sorrento Therapeutics Stock Is Crashing Today
A bankruptcy filing is weighing on the drugmaker's shares today.
Why Sorrento Therapeutics Stock Is on the Rise Today
The drugmaker's stock is moving upward today in sympathy with the broader biopharmaceutical industry.
Why Sorrento Therapeutics' Shares Tumbled 23.4% in September
Sorrento's financials are not helping it in the current down market.
Why Sorrento Therapeutics Stock Is Marching Higher Today
An FDA fast track designation for a high-value product candidate is powering the biotech's shares higher today.
2 Penny Stocks That Could Make You Filthy Rich
These two penny stocks could generate life-changing gains for early shareholders.
Why Sorrento Therapeutics Stock Is Popping Today
A positive clinical readout in lung cancer is fueling the biotech's rally today.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.